Today: 3 July 2026
Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat
28 January 2026
1 min read

Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

New York, Jan 28, 2026, 14:38 EST — Regular session

  • Coinbase shares edged up roughly 0.2% in afternoon trading, holding steady for the day
  • The UK watchdog has banned a Coinbase ad campaign themed around the cost of living, citing issues with its crypto risk messaging
  • Traders are focused on regulatory cues and Coinbase’s earnings report due Feb. 12

Shares of Coinbase Global (COIN.O) nudged up 0.2% to $211.24 Wednesday afternoon, following a UK ad watchdog’s ban on a Coinbase campaign that exploited cost-of-living concerns. The move underscores ongoing regulatory crackdowns on crypto marketing.

The timing is crucial as Coinbase pushes to boost activity on its app by adding products that resemble a traditional brokerage. Last month, it started introducing stock trading and “prediction markets” — event contracts that trade like markets and settle based on real-world outcomes — alongside its crypto offerings. Coinbase

Regulatory scrutiny is tightening around event markets. The Coalition for Prediction Markets—backed by Coinbase, Kalshi, and Robinhood—took out a full-page ad in the Washington Post on Wednesday, urging Congress to collaborate with the industry to “keep prediction markets safe and transparent,” according to Business Insider. The ad highlights that “CFTC regulated prediction markets (already) ban insider trading,” while a coalition spokesperson described the campaign as the “opening salvo” of a planned seven-figure effort. Business Insider

Britain’s Advertising Standards Authority flagged Coinbase’s ads as irresponsible, claiming they implied crypto was a fix for “prevalent financial concerns” while minimizing the risks, the Guardian reported. Coinbase pushed back, saying it “fundamentally disagree[d]” with the decision and framed the campaign as a critique of the financial system—not a simple solution, the report added. The Guardian

Crypto prices edged higher. Bitcoin climbed roughly 1.3%, hitting around $89,294. Ether gained about 1.1%.

Coinbase is pushing deeper into event contracts and stock trading to cut its dependence on crypto transaction fees, which can fluctuate wildly with market moods. “We aim to offer the greatest variety of contracts available on one platform,” Max Branzburg, head of consumer and business products at Coinbase, said last month, outlining the company’s move beyond just crypto. Reuters

Politics remains a key factor. The top pro-crypto super PAC, Fairshake, enters the 2026 midterms sitting on over $193 million in cash, Axios reported. That total includes a hefty $25 million donation from Coinbase.

That growth isn’t without risks. Stricter advertising rules in key markets or a mix of event contract regulations might delay product launches and hike compliance expenses. Plus, a steep drop in crypto prices could quickly sap trading volumes.

Coinbase is set to release its fourth-quarter and full-year 2025 earnings on Feb. 12, after the market closes. The company will hold a webcast at 2:30 p.m. PT.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus
Previous Story

Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus

Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings
Next Story

Sandisk stock price jumps 8% as storage rally builds ahead of SNDK earnings

Go toTop